Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148
暂无分享,去创建一个
M. Corada | F. Orsenigo | F. Breviario | M. Lampugnani | E. Dejana | R. Kemler | Takamune Takahashi | T. Daniel | A. Zanetti | G. Balconi | A. Cattelino
[1] Paul A. Fleming,et al. A Mutant Receptor Tyrosine Phosphatase, CD148, Causes Defects in Vascular Development , 2003, Molecular and Cellular Biology.
[2] N. Tonks,et al. Hepatocyte Growth Factor Receptor Tyrosine Kinase Met Is a Substrate of the Receptor Protein-tyrosine Phosphatase DEP-1* , 2003, The Journal of Biological Chemistry.
[3] H. Schwarz,et al. β-Catenin is not required for proliferation and differentiation of epidermal mouse keratinocytes , 2002, Journal of Cell Science.
[4] M. Corada,et al. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. , 2002, Blood.
[5] Elisabetta Dejana,et al. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Clevers,et al. WNT Signaling and Lymphocyte Development , 2002, Cell.
[7] Avri Ben-Ze'ev,et al. The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.
[8] P. Carmeliet,et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro‐angiogenic therapy , 2002, The EMBO journal.
[9] M. Corada,et al. VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. , 2002, Molecular biology of the cell.
[10] M. Corada,et al. Vascular Endothelial Growth Factor Induces Shc Association With Vascular Endothelial Cadherin: A Potential Feedback Mechanism to Control Vascular Endothelial Growth Factor Receptor-2 Signaling , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[11] K. Pumiglia,et al. Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation* , 2001, The Journal of Biological Chemistry.
[12] B. Gumbiner,et al. Adhesion signaling: How β-catenin interacts with its partners , 2001, Current Biology.
[13] R. Foisner,et al. E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity , 2001, The Journal of cell biology.
[14] M. Shibuya,et al. A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells , 2001, The EMBO journal.
[15] B. Gumbiner,et al. E-Cadherin Suppresses Cellular Transformation by Inhibiting β-Catenin Signaling in an Adhesion-Independent Manner , 2001, The Journal of cell biology.
[16] N. Rahimi,et al. Identification of Tyrosine Residues in Vascular Endothelial Growth Factor Receptor-2/FLK-1 Involved in Activation of Phosphatidylinositol 3-Kinase and Cell Proliferation* , 2001, The Journal of Biological Chemistry.
[17] A. McMahon,et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. , 2001, Development.
[18] B. Neel,et al. Combinatorial control of the specificity of protein tyrosine phosphatases. , 2001, Current opinion in cell biology.
[19] S. Tangye,et al. Protein Tyrosine Phosphatase CD148-Mediated Inhibition of T-Cell Receptor Signal Transduction Is Associated with Reduced LAT and Phospholipase Cγ1 Phosphorylation , 2001, Molecular and Cellular Biology.
[20] M. Corada,et al. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. , 2001, Blood.
[21] E. Fuchs,et al. Hyperproliferation and Defects in Epithelial Polarity upon Conditional Ablation of α-Catenin in Skin , 2001, Cell.
[22] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[23] J. Gutkind,et al. Signaling from E-cadherins to the MAPK Pathway by the Recruitment and Activation of Epidermal Growth Factor Receptors upon Cell-Cell Contact Formation* , 2000, The Journal of Biological Chemistry.
[24] G. Viglietto,et al. Rat Protein Tyrosine Phosphatase η Suppresses the Neoplastic Phenotype of Retrovirally Transformed Thyroid Cells through the Stabilization of p27Kip1 , 2000, Molecular and Cellular Biology.
[25] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[26] P. Polakis. Wnt signaling and cancer. , 2000, Genes & development.
[27] E. Dejana,et al. Development of endothelial cell lines from embryonic stem cells: A tool for studying genetically manipulated endothelial cells in vitro. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[28] M. Woolkalís,et al. SHP2 Association with VE-Cadherin Complexes in Human Endothelial Cells Is Regulated by Thrombin* , 2000, The Journal of Biological Chemistry.
[29] Napoleone Ferrara,et al. Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.
[30] D. Abrahamson,et al. Endothelial localization of receptor tyrosine phosphatase, ECRTP/DEP-1, in developing and mature renal vasculature. , 1999, Journal of the American Society of Nephrology : JASN.
[31] N. Rahimi,et al. A role for cadherin-5 in regulation of vascular endothelial growth factor receptor 2 activity in endothelial cells. , 1999, Molecular biology of the cell.
[32] M. Corada,et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[33] P. Carmeliet,et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.
[34] N. Ferrara. Molecular and biological properties of vascular endothelial growth factor , 1999, Journal of Molecular Medicine.
[35] J. Pouysségur,et al. Confluence of Vascular Endothelial Cells Induces Cell Cycle Exit by Inhibiting p42/p44 Mitogen-Activated Protein Kinase Activity , 1999, Molecular and Cellular Biology.
[36] M. Shibuya,et al. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells , 1999, Oncogene.
[37] M. Schwartz,et al. Interactions between mitogenic stimuli, or, a thousand and one connections. , 1999, Current opinion in cell biology.
[38] Z. Kam,et al. p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry , 1999, Oncogene.
[39] B. Keyt,et al. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.
[40] Robert S. Kerbel,et al. E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.
[41] D. Hicklin,et al. Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy , 1998, Cancer and Metastasis Reviews.
[42] V. Dixit,et al. Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[43] S Esser,et al. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. , 1997, Journal of cell science.
[44] M. Shibuya,et al. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts , 1997, Oncogene.
[45] B. Gumbiner,et al. Cell contact-dependent signaling. , 1996, Developmental biology.
[46] M. Oishi,et al. Expression of the Protein Tyrosine Phosphatase β2 Gene in Mouse Erythroleukemia Cells Induces Terminal Erythroid Differentiation* , 1996, The Journal of Biological Chemistry.
[47] L. Reichardt,et al. Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex , 1996, The Journal of cell biology.
[48] M. Corada,et al. Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). , 1996, The Journal of clinical investigation.
[49] J. Lilien,et al. Regulated binding of PTP1B-like phosphatase to N-cadherin: control of cadherin-mediated adhesion by dephosphorylation of beta-catenin , 1996, The Journal of cell biology.
[50] A. Ullrich,et al. Association of Human Protein-tyrosine Phosphatase κ with Members of the Armadillo Family* , 1996, The Journal of Biological Chemistry.
[51] K. Takahashi,et al. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. , 1996, Experimental cell research.
[52] D. Rimm,et al. Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo , 1995, The Journal of cell biology.
[53] F. Graham,et al. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression , 1995, Journal of virology.
[54] H. Aberle,et al. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor , 1994, The Journal of cell biology.
[55] N. Tonks,et al. Expression of DEP-1, a receptor-like protein-tyrosine-phosphatase, is enhanced with increasing cell density. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Brunet,et al. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.
[57] M. Lampugnani,et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts , 1992, The Journal of cell biology.
[58] B. Geiger,et al. The effect of tyrosine‐specific protein phosphorylation on the assembly of adherens‐type junctions. , 1992, The EMBO journal.
[59] R. Kemler. /-Catenin Mediates the Interaction of the Cadherin-Catenin Complex with Epidermal Growth Factor Receptor , 2002 .
[60] S. Hoffman,et al. Regulated Binding of a PTP 1 B-like Phosphatase to N-Cadherin : Control of Cadherin-mediated Adhesion by Dephosphorylation of-Catenin , 2002 .
[61] A. Schönthal,et al. p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression. , 2000, Cancer research.
[62] P. D’Amore,et al. Mechanisms of endothelial growth control. , 1992, American journal of respiratory cell and molecular biology.